PMC:7352545 / 74935-75078 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T213","span":{"begin":63,"end":65},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"}],"text":" against SARS-CoVs because the SARS-CoV receptor ACE2 contains SA species. In fact, CLQ exhibits in vitro anti-SARS-CoV-1 activity via defectiv"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T287","span":{"begin":9,"end":13},"obj":"Disease"},{"id":"T288","span":{"begin":31,"end":39},"obj":"Disease"},{"id":"T289","span":{"begin":111,"end":119},"obj":"Disease"}],"attributes":[{"id":"A287","pred":"mondo_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A288","pred":"mondo_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A289","pred":"mondo_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" against SARS-CoVs because the SARS-CoV receptor ACE2 contains SA species. In fact, CLQ exhibits in vitro anti-SARS-CoV-1 activity via defectiv"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1053","span":{"begin":122,"end":130},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":" against SARS-CoVs because the SARS-CoV receptor ACE2 contains SA species. In fact, CLQ exhibits in vitro anti-SARS-CoV-1 activity via defectiv"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T466","span":{"begin":63,"end":65},"obj":"Chemical"}],"attributes":[{"id":"A76511","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_35962"},{"id":"A10197","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_38358"},{"id":"A2161","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_45373"},{"id":"A95025","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_74801"},{"id":"A3805","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"}],"text":" against SARS-CoVs because the SARS-CoV receptor ACE2 contains SA species. In fact, CLQ exhibits in vitro anti-SARS-CoV-1 activity via defectiv"}